The ALS Association provides the latest research news & information relevant to the fight against this disease through press releases, blog posts, research webinars, newsletters and more.
Keep up-to-date on what’s going on in the world of ALS research and learn more about ALS research.
Every month, The ALS Association and the Northeast ALS Consortium (NEALS) invites leading ALS experts to discuss their area of expertise in our research webinar series. Register for an upcoming webinar below.
Monday, May 7, 2018, 4:00 p.m. EDT
Speaker: Sabrina Paganoni, MD, Massachusetts General Hospital
Dr. Sabrina Paganoni will discuss CENTAUR, a trial for people with ALS. CENTAUR ("Combination of Phenylbutyrate and Tauroursodeoxycholic Acid") is a Phase 2 trial testing the efficacy and safety of AMX0035 for the treatment of ALS as well as its impact on several disease biomarkers. CENTAUR is expected to enroll 132 participants nationwide.
Friday, May 18, 2018, 12:00 p.m. EDT
Speaker: John M. Costello, MA, CCC-SLP
This webinar will focus on a variety of communication supports that a person with ALS may consider including early simple speech and writing strategies, creating and learning simple quick access tools, message and voice banking and examples of sophisticated technologies that are currently available to support communication, email, texting, telephone and environmental controls.
On our blog, The ALS Association, or one of our guest bloggers, discusses breaking research news in a more casual, easy-to-understand format than you may find in your average scientific journal.